Basilea Pharmaceutica AG (BPMUF)
Basilea Pharmaceutica Market Cap : 798.89M for May 21, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Kuros Biosciences Ltd. | 969.69M |
| Santhera Pharmaceuticals Holding AG | 337.73M |
| BeOne Medicines Ltd. | 32.12B |
| AC Immune SA | 290.05M |
| CRISPR Therapeutics AG | 4.813B |
Market Cap Related Metrics
| PE Ratio | 17.73 |
| PS Ratio | 3.175 |
| PEG Ratio | 0.0293 |
| Price to Free Cash Flow | 12.05 |
| Price | 65.10 |
| Earnings Yield | 5.64% |
| PEGY Ratio | 0.0293 |
| Operating PE Ratio | 14.33 |
| Normalized PE Ratio | 17.73 |